Understanding the Performance Dynamics of Equal-Weighted ETFs Against Market-Cap-Weighted Funds

David Rubenstein

Co-founder of The Carlyle Group, author, and interviewer discussing economic history and leadership.

Exchange-Traded Funds (ETFs) are designed to simplify investment in a diverse portfolio of stocks. However, when an ETF's assets become too concentrated in a few top holdings, its effectiveness as a diversification tool diminishes. The Invesco S&P 500 Equal Weight ETF (NYSEMKT: RSP) was created to address this issue by allocating investments equally across all 500 S&P components, aiming for both enhanced diversification and a more balanced return profile. This alternative structure ensures that each stock contributes meaningfully to the fund's overall performance. This report explores the historical performance of this equal-weighted fund in contrast to its market-capitalization-weighted counterparts.

A preliminary look at the Invesco S&P 500 Equal Weight ETF's performance might suggest it prioritizes stability over aggressive growth. For example, during the bull markets of 2023, 2024, and 2025, the equal-weighted ETF generated positive returns but significantly trailed market-cap-weighted funds by 12 percentage points in the first two years and over six percentage points in 2025. Conversely, in the bear market of 2022, the Invesco ETF, despite losing value, still outperformed the broader S&P 500 by nearly seven percentage points, demonstrating its defensive characteristics during downturns.

However, extending the historical view reveals a more complex picture. In 2021, a strong bull market year, the Invesco ETF surprisingly surpassed the S&P 500's returns. Yet, in 2018, when the broader market experienced a weak period, the Invesco ETF suffered greater losses, falling approximately 8% compared to the S&P's 4%-5% decline. Over the long term, specifically the past decade, the Invesco ETF has underperformed, with average annual returns of 11.47%, nearly three percentage points behind the S&P 500. This trend continues over a 15-year horizon, where it lags at 11.35% versus the S&P 500's 13.43%. While a few percentage points might seem minor, the impact of compounding over extended periods can lead to substantial differences in investor wealth.

A primary factor contributing to the Invesco ETF's divergent performance is its sector allocation, which significantly differs from that of market-cap-weighted funds. The equal-weight fund allocates only about 16% of its assets to technology stocks, a stark contrast to the 34% typically found in market-cap-weighted ETFs. Similar disparities exist in communication services, where market-cap-weighted funds have higher allocations due to the classification of certain tech giants within these sectors. Conversely, the Invesco ETF holds larger positions in defensive sectors such as consumer discretionary, healthcare, and utilities. While these allocations enhance diversification, they have concurrently dampened its performance during recent growth-driven market cycles.

It is tempting to dismiss an investment vehicle that consistently underperforms the broader market. Nevertheless, an ETF's performance can fluctuate significantly with changing market dynamics. The current underperformance might reverse under different economic or market conditions, where its sector biases could become advantageous. Future analyses will delve deeper into the potential for the Invesco ETF's prospects to improve, offering insights into whether its unique structure is poised for a rebound in the foreseeable future.

you may like

youmaylikeicon
Gig Economy: A Deep Dive into Worker Earnings and Platform Dynamics

Gig Economy: A Deep Dive into Worker Earnings and Platform Dynamics

By Mariana Mazzucato
T1 Energy Accelerates AI Data Center Initiatives in Norway with 50MW Grid Allocation

T1 Energy Accelerates AI Data Center Initiatives in Norway with 50MW Grid Allocation

By Strive Masiyiwa
Saab's Strategic Ascent: How Geopolitical Shifts Fuel Defense Sector Growth

Saab's Strategic Ascent: How Geopolitical Shifts Fuel Defense Sector Growth

By Michele Ferrero
Amazon's Enduring Market Dominance and Growth Trajectory

Amazon's Enduring Market Dominance and Growth Trajectory

By Mariana Mazzucato
Janus Henderson AAA CLO ETF: A Reliable Income Generator with Low Risk

Janus Henderson AAA CLO ETF: A Reliable Income Generator with Low Risk

By Robert Kiyosaki
Analyst Firms Adjust Price Targets for Toast (TOST) Following Recent Quarterly Performance

Analyst Firms Adjust Price Targets for Toast (TOST) Following Recent Quarterly Performance

By Robert Kiyosaki
Healthpeak's Senior Housing: Unlocking Hidden Value Through Janus Living IPO

Healthpeak's Senior Housing: Unlocking Hidden Value Through Janus Living IPO

By David Rubenstein
Leading Financial Institutions Express Continued Optimism for Dynatrace (DT)

Leading Financial Institutions Express Continued Optimism for Dynatrace (DT)

By David Rubenstein
Confluent Cloud for Government Achieves FedRAMP Authorization

Confluent Cloud for Government Achieves FedRAMP Authorization

By Mariana Mazzucato
Yum! Brands' Strategic Growth: A Detailed Overview of Taco Bell's Success, Global Expansion, and Shareholder Value

Yum! Brands' Strategic Growth: A Detailed Overview of Taco Bell's Success, Global Expansion, and Shareholder Value

By Suze Orman
Agnico Eagle Navigates Gold Price Fluctuations with Strong Fundamentals

Agnico Eagle Navigates Gold Price Fluctuations with Strong Fundamentals

By Strive Masiyiwa
FedEx to Close Nine Parcel Centers in New York Amidst Network Restructuring

FedEx to Close Nine Parcel Centers in New York Amidst Network Restructuring

By David Rubenstein
Financial Analyst vs. Financial Consultant: A Career Comparison

Financial Analyst vs. Financial Consultant: A Career Comparison

By Lisa Jing
KeyBanc Initiates Coverage on Chime Financial with Overweight Rating

KeyBanc Initiates Coverage on Chime Financial with Overweight Rating

By Michele Ferrero
Tenax Therapeutics: A High-Stakes Wager on Oral Levosimendan

Tenax Therapeutics: A High-Stakes Wager on Oral Levosimendan

By Mariana Mazzucato